NCT03263832 (BJIBiofilm) is a clinical trial of Antibiofilmogramme in Prosthetic Joint Infection, sponsored by BioFilm Control.

Who is sponsoring NCT03263832?

NCT03263832 is sponsored by BioFilm Control.

What drugs are being tested in NCT03263832?

Interventions in NCT03263832: Antibiofilmogramme.

What condition does NCT03263832 study?

NCT03263832 studies Prosthetic Joint Infection, Staphylococcus Aureus, Biofilm.

Is NCT03263832 still recruiting?

NCT03263832 is currently status unknown. Last updated 2 March 2021.

Last reviewed 2021-03-02 · How we verify

NCT03263832: BJIBiofilm

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the Antibiofilmogramme Test During Orthopaedic Device-Related Infection

Status unknown Last updated 2 March 2021

What this trial tests

trial testing Antibiofilmogramme in Prosthetic Joint Infection in 45 participants. Status unknown.

Timeline

1 June 2015

Primary endpoint
28 February 2018

1 December 2021

Quick facts

Lead sponsor	BioFilm Control
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	45
Start date	1 June 2015
Primary completion	28 February 2018
Estimated completion	1 December 2021
Sites	1 location across France

Drugs / interventions tested

Antibiofilmogramme — full drug profile →

Conditions studied

Prosthetic Joint Infection — all drugs for Prosthetic Joint Infection →
Staphylococcus Aureus — all drugs for Staphylococcus Aureus →
Biofilm — all drugs for Biofilm →

Sponsor

BioFilm Control

Who can join

18 and older, any sex, with Prosthetic Joint Infection or Staphylococcus Aureus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an observational study that does not change routine care. The primary objective of this study is to investigate the correlation between the administration of an antibiotherapy able to prevent biofilm formation according to the results of the Antibiofilmogramme test, and the relapse of the infection for patient with orthopaedic device-related infection.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Antibiofilmogramme

Trials testing the same drug.

NCT02378493 — Evaluation of the Antibiofilmogramme® Test During Diabetic Foot Infections · NA · completed

Other recruiting trials for Prosthetic Joint Infection

Currently open trials in the same condition.

NCT07107685 — Prosthetic Joint Infection : Lessons From Deceased Patients in Critical Care. · recruiting
NCT06627842 — OsteoArticular Sepsis in Intensive Care unitS · recruiting
NCT04650607 — Phage Safety Cohort Study · recruiting
NCT04858217 — Periprosthetic Joint Infections: Diagnostic Accuracy and Cost-effectiveness Analysis of Serum and Synovial Markers · recruiting
NCT04724603 — Phage Safety Retrospective Cohort Study · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03263832 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by BioFilm Control
Last refreshed: 2 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03263832.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing